Dr. Alan D. Rogol
Pediatrics (Pediatrics Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatrics Physician primary
VA license 0101026539 -
Pediatric Endocrinology Physician
IN license 01064703
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 4 companies reported 12 payments worth $8,625 in total to this clinician.
| Tolmar, Inc. | $4,146 |
|---|---|
| Ascendis Pharma Endocrinology Inc | $3,408 |
| Eton Pharmaceuticals, Inc. | $1,000 |
| BioMarin Pharmaceutical Inc. | $70.72 |
| Consulting Fee | $8,483 |
|---|---|
| Food and Beverage | $142 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Tolmar, Inc. Apr 3, 2025 | Consulting Fee | $1,873 |
| Tolmar, Inc. Aug 8, 2025 | Consulting Fee FENSOLVI · Central Precocious Puberty (CPP) | $1,605 |
| Ascendis Pharma Endocrinology Inc Aug 15, 2025 | Consulting Fee | $1,570 |
| Eton Pharmaceuticals, Inc. Jan 27, 2025 | Consulting Fee ALKINDI; KHINDIVI; INCRELEX · Endocrinology | $1,000 |
| Ascendis Pharma Endocrinology Inc Oct 30, 2025 | Consulting Fee Skytrofa · Endocrinology | $785 |
| Ascendis Pharma Endocrinology Inc Jan 1, 2025 | Consulting Fee Skytrofa · Endocrinology | $589 |
| Tolmar, Inc. Jul 17, 2025 | Consulting Fee FENSOLVI · Central Precocious Puberty (CPP) | $401 |
| Ascendis Pharma Endocrinology Inc Apr 23, 2025 | Consulting Fee Skytrofa · Endocrinology | $393 |
| Tolmar, Inc. Mar 6, 2025 | Consulting Fee JATENZO · Endogenous Testosterone Replacement Therapy | $268 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.